KIRKLAND, QC, May 1, 2012 /CNW Telbec/ - Merck Canada supports Health Canada's initiative to ensure Canadians have quicker access to products that are switched from prescription to over-the-counter

BILLERICA, Mass., Feb.

ROCKLAND, Mass. and NEW YORK, Jan. 23, 2012 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc.

Zyngenia, Inc., a biopharmaceutical company developing the next generation of antibody-based drugs called Zybodies(TM), announced today that it has promoted David M. Hilbert, Ph.D., to Chief Scientific Officer and appointed Daniel L. Menichella as Chief Business Officer.

IRVING, Texas, Oct. 14, 2011 /PRNewswire/ -- Reata Pharmaceuticals, Inc.